Effect of infliximab treatment on T cell cytokine responses in spondylarthropathy: comment on the article by Zou et al.
Baeten
Dominique
D
Vandooren
Bernard
B
De Rycke
Leen
L
Veys
Eric M
EM
De Keyser
Filip
F
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016207:Cytokines / Q000378:metabolism*; D006801:Humans; D000069285:Infliximab; D025242:Spondylarthropathies / Q000188:drug therapy* / Q000378:metabolism*; D013601:T-Lymphocytes / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D016207:Cytokines; D000069285:Infliximab